Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
Teva's $40.5 billion generics deal with Allergan hits FTC snag
BioPharma Dive
Tue, 03/15/16 - 10:16 pm
Teva Pharmaceutical
Allergan
generics
FTC
M&A
First generic version of Viagra in the U.S. approved by FDA
BioPharma Dive
Thu, 03/10/16 - 09:41 pm
generics
Viagra
FDA
erectile dysfunction
Pfizer
Teva Pharmaceutical
Teva's $40.5B deal for Allergan generics arm reportedly close to EU approval
BioPharma Dive
Thu, 03/10/16 - 10:53 am
Teva Pharmaceutical
Allergan
generics
M&A
Europe
Drugmakers exploit REMS to restrict generics, and it doesn't bode well for biosimilars
Fierce Pharma
Tue, 03/8/16 - 10:21 am
REMS
generics
biosimilars
Why the Patent Cliff Is a Key Driver of Generic Drug Growth
Yahoo/Market Realist
Thu, 03/3/16 - 02:55 pm
patents
patent cliff
generics
Teva planning global rebrand as it works to close Allergan generics deal
BioPharma Dive
Thu, 03/3/16 - 10:39 am
Teva Pharmaceutical
rebranding
Allergan
generics
M&A
Teva Says Its Generic EpiPen Will Be 'Significantly Delayed'
Yahoo/Benzinga
Tue, 03/1/16 - 03:34 pm
Teva Pharmaceutical
generics
EpiPen
Mylan
How to bring down generic drug costs? Tweak the FDA's approval rules, health experts say
Fierce Pharma
Thu, 02/25/16 - 03:21 pm
generics
drug pricing
FDA
drug approvals
Sandoz asks Supreme Court to nix 'exclusivity windfall' delaying biosimilar launches
Fierce Pharma
Sat, 02/20/16 - 09:22 am
Sandoz
generics
Supreme Court
exclusivity
biosimilars
Zarxio
Teva to hawk $1 billion in assets to clear massive Allergan generics deal
BioPharma Dive
Fri, 02/19/16 - 11:11 am
Teva
Europe
Allergan
generics
M&A
Teva Said to Seek Fast EU Approval for Allergan Unit Bid
Bloomberg
Thu, 02/18/16 - 09:34 am
Teva Pharmaceutical
M&A
Allergan
Europe
generics
GlaxoSmithKline Fined $54.3 Million for Preventing Generic Competition
Fortune
Fri, 02/12/16 - 04:19 pm
GSK
UK
generics
competition
Seroxat
antidepressants
Eli Lilly Just Lost the Latest Round in its Patent Battle
Fortune
Fri, 02/12/16 - 10:01 am
Eli Lilly
patents
Alimta
lung cancer
UK
Allergan
generics
The Generic Drug Battle
Yahoo/Benzinga
Wed, 02/10/16 - 10:29 am
generics
biosimilars
JNJ
Pfizer
Remicade
Takeda-Teva JV 'could be a trendsetter' as Japan pushes for generics: analyst
Fierce Pharma
Mon, 02/8/16 - 09:33 pm
Takeda
Teva Pharmaceutical
Japan
generics
Old Novartis cancer flagship Gleevec heads to pharmacies as lower-cost generic
BioPharma Dive
Wed, 02/3/16 - 08:59 pm
Novartis
Gleevec
Sun Pharma
generics
Novartis braces for multibillion-dollar generics hit as Gleevec copies launch
Fierce Pharma
Mon, 02/1/16 - 11:13 pm
Novartis
generics
Gleevec
Sun Pharma
blood cancer
Teva’s Generic Segment: What It Looks Like Pre-4Q15
Yahoo/Market Realist
Fri, 01/15/16 - 02:32 pm
Teva Pharmaceutical
generics
U.S. patent office rules against Amgen Humira challenge
Yahoo/Reuters
Thu, 01/14/16 - 08:49 pm
patents
Amgen
Humira
generics
AbbVie
Pay-for-delay deals continue to fall following FTC court victory
BioPharma Dive
Thu, 01/14/16 - 10:16 am
pay-for-delay
FTC
generics
antitrust
Pages
« first
‹ previous
…
32
33
34
35
36
37
38
39
40
…
next ›
last »